• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kronos Bio Inc (NQ: KRON )

    0.8500 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Kronos Bio Inc

    < Previous 1 2 Next >
    Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
    Evolent Health, Kronos Bio, Saint-Gobain, Shell and Unilever are on the sell-side this week. Benzinga's Deal Dispatch has the latest M&A updates. 
    Via Benzinga
    KRON Stock Earnings: Kronos Bio Beats EPS, Beats Revenue for Q2 2024
    KRON stock results show that Kronos Bio beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Recap: Kronos Bio Q4 Earnings
    Via Benzinga
    Kronos Bio: Q1 Earnings Insights
    Via Benzinga
    Expert Ratings for Kronos Bio
    Via Benzinga
    Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    KRON Stock Earnings: Kronos Bio Misses EPS, Beats Revenue for Q1 2024
    KRON stock results show that Kronos Bio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    KRON Stock Earnings: Kronos Bio Beats EPS, Beats Revenue for Q4 2023
    KRON stock results show that Kronos Bio beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Cancer Player Kronos Bio To Stop Lanraplenib Combo Therapy Blood Cancer Study
    Kronos Bio Inc (NASDAQ: KRON) says that after the review of data from the phase 1b portion of its phase 1b/2 trial of lanraplenib in combination with gilteritinib in FLT3-mutated relapsed/refractory... 
    Via Benzinga
    Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates... 
    Via Benzinga
    Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
    Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday's session, 99 companies made new 52-week lows. 
    Via Benzinga
    5 Most Expensive Health Care Stocks You Should Worry About
    The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
    Via Benzinga
    Palo Alto To Surge Around 38%? Plus This Analyst Predicts $65 For Helmerich & Payne
    Barclays raised the price target on Palo Alto Networks, Inc. (NASDAQ: PANW) from $200 to $215. Barclays analyst Saket Kalia maintained an Overweight rating on the stock. Palo Alto Networks shares fell... 
    Via Benzinga
    Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. 
    Via Benzinga
    Recap Of Monday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      OnFriday, 143 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      During Wednesday's session, 107 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 79 companies reached new 52-week lows. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
    Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.